What Is The Long-Term Forecast For The Global Hypertrophic And Keloid Scar Treatment Market Growing At 10.1% CAGR?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What CAGR And Valuation Are Anticipated For The Hypertrophic And Keloid Scar Treatment Market?
The market for hypertrophic and keloid scar treatment has seen significant expansion over the past few years. The market size is projected to escalate from $7.72 billion in 2024 to $8.49 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.0%. The remarkable growth during the historic period is due to the increasing prevalence of hypertrophic and keloid scars, advancements in scar evaluation, widespread use of topical treatments and surgical procedures, along with a heightened patient desire for scar enhancement.
The market size of the hypertrophic and keloid scar treatment is projected to experience a rapid expansion in the coming years, with an estimated value of $12.46 billion in 2029 and a compound annual growth rate (CAGR) of 10.1%. The growth in the predicted period can be credited to factors such as the development of minimally invasive procedures, improvements in scar revision methods, increased interest in combination treatments, the rise in awareness and prompt intervention, and international aesthetic trends. The forecast period is also expected to see significant trends such as the rise of injectable therapies, combination treatments for synergistic outcomes, patient-focused approaches, scar evaluation technologies, and the use of telemedicine for follow-ups and consultations.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp
What Are The Primary Factors Supporting The Hypertrophic And Keloid Scar Treatment Market Expansion?
The growth of the hypertrophic and keloid scar treatment market is anticipated to be fuelled by a rise in road mishaps and burn incidents. Road incidents refer to occurrences on the road involving at least one vehicle and people. These incidents necessitate immediate action and appropriate preventative measures to ensure effective treatment. Hypertrophic and keloid scar treatments are utilized to aid those injured in road incidents by reducing the prominence and tension of the scar. The spike in road mishaps and burn incidents thus catalyzes the hypertrophic and keloid scar treatment market’s expansion. For example, the National Highway Traffic Safety Administration, a US federal government agency within the Department of Transportation, reported in August 2022 that around 9,560 individuals lost their lives in vehicular traffic accidents in the initial three months of 2022, marking an approximate 7% increase from the 8,935 deaths during the same span in 2021. Moreover, the fatality rate increased from the projected 1.25 deaths per 100 million vehicle miles in the first quarter of 2021, to 1.27 in the first quarter of 2022. Consequently, the rise in road mishaps and burn incidents will spur growth in the hypertrophic and keloid scar treatment market.
Which Segments Define The Structure Of The Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatmentmarket covered in this report is segmented –
1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
2) By Products: Topical Products; Laser Products; Injectables; Other Products
3) By Scar: Hypertrophic Scars; Keloid Scars
4) By End-Use: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy; Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision; Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings; Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment; Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy; Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection; Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy; Radiotherapy; Interferon Therapy
Which Disruptive Trends Are Driving Change Across The Hypertrophic And Keloid Scar Treatment Market?
Leading businesses in the hypertrophic and keloid scar treatment market are concentrating their efforts on creating proven methods utilizing silicon, such as medical-grade silicone strips, to boost their market profitability. These strips are therapeutic items composed of top-grade silicone material, specifically designed to encourage scar healing and reduction. To illustrate, Scar Erase, a British company that specializes in silicone-based scar reduction therapy, in April 2023, introduced clinically examined and cost-effective Scar Erase silicone strips for healing scars. Featuring 3mm of medical-grade silicone, these strips are effective in treating a variety of scars such as hypertrophic, keloid, post-operative, and stretch marks. This silicone solution encompasses the scar area, fostering hydration and the best healing conditions, leading to noticeable reductions in scar texture, color, and elevation. The design is geared towards comfort and subtlety, offering a viable at-home solution for scar treatment.
Who Are The Primary Market Leaders In The Hypertrophic And Keloid Scar Treatment Market?
Major companies operating in the hypertrophic and keloid scar treatment market include Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Revitol Corporation Inc., Scarfade, Biodermis, Mederma, Silagen
Access The Complete Report Here:
What Regional Factors Are Accelerating Growth In The Hypertrophic And Keloid Scar Treatment Market?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp
Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2025, By The Business Research Company
Dental Diagnostic Imaging Devices And Equipment Global Market Report 2025
Diagnostic And Monitoring Ophthalmic Devices And Equipment Market 2025
Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
